After the Philippines conducted a successful clinical study of the effectiveness of virgin coconut oil (VCO) as a functional food that aids in the treatment of COVID-19 patients, another coconut-producing country will conduct its own clinical trial on VCO.
Sri Lanka will adopt a similar clinical trial on VCO as an adjunct therapy for COVID-19 patients.
MANILA — Sri Lanka has started coordinating with the Department of Science and Technology-Food and Nutrition Research Institute (DOST-FNRI) for their VCO clinical study as they test on its therapeutic benefits against coronavirus.
The cooperation is being planned out with Sri Lanka counterparts and will soon meet with FNRI director Imelda Agdeppa and Ateneo de Manila University professor Fabian Dayrit. They both led the VCO clinical trials in Santa Rosa.
“They are setting a meeting with us to discuss our findings and maybe possibly conduct the study in their country,” Ms Agdeppa sain in an interview with The Star.
The Journal of Functional Foods, an international scientific journal published the results of the DOST-FNRI VCO clinical trials in May. It covered 57 adults at the Santa Rosa Community Hospital and the Santa Rosa COVID-19 Quarantine Facility in Canossa Institute. The subjects were admitted or isolated for being suspected or probably infected by COVID-19.
DOST-FNRI is set to expand the VCO clinical trials in Valenzuela and Muntinlupa within the year. It targets 120 participants with mild to moderate COVID-19, but is having difficulty enlisting participants without comorbidities.
Also looking into the capacity of VCO to fight COVID-19 is the in-vitro study partnership study of the Ateneo de Manila University with Duke University-National University of Singapore. Funded by the DOST, it is providing supporting evidence on VCO as a cure for COVID-19.
Led by professor Dayrit, the study found that at the least VCO was helpful in fighting SARS-CoV-2 which causes COVID-19 at low viral load.
An ongoing clinical trial on VCO as a cure for moderate-to-severe COVID-19 cases is conducted by the University of the Philippines in Manila and funded by the DOST with the Philippine Council for Health Research and Development. (RA/Headline PH)